+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Onychomycosis (Tinea Unguium) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768238
  • Report
  • 94 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Apricus Biosciences Inc
  • DermResearch Inc
  • GlaxoSmithKline Plc
  • Moberg Pharma AB
  • Nestle SA
  • Novartis AG
  • MORE
The global clinical trial report- “2019 Onychomycosis (Tinea Unguium) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Onychomycosis (Tinea Unguium). It presents in-depth analysis of Onychomycosis (Tinea Unguium) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Onychomycosis (Tinea Unguium).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Onychomycosis (Tinea Unguium) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Onychomycosis (Tinea Unguium)

The research work is prepared through extensive and continuous research on Onychomycosis (Tinea Unguium) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Onychomycosis (Tinea Unguium) patients are identified
  • The report includes panorama of Onychomycosis (Tinea Unguium) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Onychomycosis (Tinea Unguium) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Apricus Biosciences Inc
  • DermResearch Inc
  • GlaxoSmithKline Plc
  • Moberg Pharma AB
  • Nestle SA
  • Novartis AG
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Onychomycosis (Tinea Unguium) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Onychomycosis (Tinea Unguium) Clinical Trials by Region
2.2.2 Average Enrollment of Onychomycosis (Tinea Unguium) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Onychomycosis (Tinea Unguium) Treatment, 2019

3. Region wise Onychomycosis (Tinea Unguium) Clinical Trials
3.1 Asia Pacific Onychomycosis (Tinea Unguium) Clinical Trials by Country
3.2 Europe Onychomycosis (Tinea Unguium) Clinical Trials by Country
3.3 North America Onychomycosis (Tinea Unguium) Clinical Trials by Country
3.4 Middle East and Africa Onychomycosis (Tinea Unguium) Clinical Trials by Country
3.5 South and Central America Onychomycosis (Tinea Unguium) Clinical Trials by Country

4. Onychomycosis (Tinea Unguium) Clinical Trial Trends
4.1 Start Year wise Onychomycosis (Tinea Unguium) Clinical Trials
4.2 Phase wise Onychomycosis (Tinea Unguium) Clinical Trials
4.3 Trial Status wise Onychomycosis (Tinea Unguium) Clinical Trials
4.4 Trial Type wise Onychomycosis (Tinea Unguium) Clinical Trials

5. Onychomycosis (Tinea Unguium) Average Enrollment Trends
5.1 Average Enrollment in Onychomycosis (Tinea Unguium) Trials by Year
5.2 Average Enrollment in Onychomycosis (Tinea Unguium) Trials by Phase
5.3 Average Enrollment in Onychomycosis (Tinea Unguium) Trials by Status
5.4 Average Enrollment in Onychomycosis (Tinea Unguium) Trials by Type of Trial

6. Companies Participating in Onychomycosis (Tinea Unguium) Clinical Trials
6.1 Onychomycosis (Tinea Unguium) Trials by Sponsor Type
6.2 Onychomycosis (Tinea Unguium) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Onychomycosis (Tinea Unguium) Trials- Phase 1
7.2 Onychomycosis (Tinea Unguium) Trials- Phase 2
7.3 Onychomycosis (Tinea Unguium) Trials- Phase 3
7.4 Onychomycosis (Tinea Unguium) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Onychomycosis (Tinea Unguium) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Onychomycosis (Tinea Unguium) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Onychomycosis (Tinea Unguium) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Onychomycosis (Tinea Unguium) Clinical Trials and Enrolment
Figure 7: North America - Country wise Onychomycosis (Tinea Unguium) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Onychomycosis (Tinea Unguium) Clinical Trials and Enrolment
Figure 9: Onychomycosis (Tinea Unguium) Clinical Trials by Phase
Figure 10: Onychomycosis (Tinea Unguium) Clinical Trials by Trial Status
Figure 11: Onychomycosis (Tinea Unguium) Clinical Trials by Type
Figure 12: Onychomycosis (Tinea Unguium) Clinical Trials by Sponsor Type
Figure 13: Onychomycosis (Tinea Unguium) Clinical Trials by Leading Sponsors
Figure 14: Onychomycosis (Tinea Unguium) Average Enrollment by Phase
Figure 15: Onychomycosis (Tinea Unguium) Average Enrollment by Trial Status
Figure 16: Onychomycosis (Tinea Unguium) Average Enrollment by Type
Figure 17: Onychomycosis (Tinea Unguium)- Average Enrolment by Type of Sponsors
Figure 18: Onychomycosis (Tinea Unguium)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Onychomycosis (Tinea Unguium) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Onychomycosis (Tinea Unguium) Clinical Trials and Enrolment
Table 5: Europe - Country wise Onychomycosis (Tinea Unguium) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Onychomycosis (Tinea Unguium) Clinical Trials and Enrolment
Table 7: North America - Country wise Onychomycosis (Tinea Unguium) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Onychomycosis (Tinea Unguium) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Onychomycosis (Tinea Unguium) Average Enrollment by Phase
Table 15: Onychomycosis (Tinea Unguium) Average Enrollment by Trial Status
Table 16: Onychomycosis (Tinea Unguium) Average Enrollment by Type
Table 17: Onychomycosis (Tinea Unguium)- Average Enrolment by Type of Sponsors
Table 18: Onychomycosis (Tinea Unguium)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Apricus Biosciences Inc
  • DermResearch Inc
  • Dr. Reddy's Laboratories Ltd
  • GlaxoSmithKline Plc
  • Moberg Pharma AB
  • Nestle SA
  • Novartis AG
  • Pfizer Inc
  • Radiant Research Inc
  • Valeant Pharmaceuticals International Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768238
Adroll
adroll